VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
INMB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
INMBINmune Bio, Inc.
$1.13$30M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksINMBQuarterly Balance Sheet

INmune Bio, Inc. (INMB) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

INmune Bio, Inc. (INMB) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

INMB Balance Sheet

Quarterly statement

INMB Balance Sheet

INmune Bio, Inc. (INMB) balance sheet — 11-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets18.71M23.8M22.82M29.89M30.67M36.03M20.96M22.66M35.85M35.49M29.82M39.94M45.61M52.61M56.88M64.67M66.66M70.55M77.06M82.61M
Cash & Short-Term Investments16.33M18.41M21.36M24.75M27.73M33.37M19.34M20.92M33.55M31.07M26M35.85M41.81M47.83M51M52.15M57.41M61.21M66.73M74.81M
Cash Only16.33M18.41M21.36M24.75M27.73M33.37M19.34M20.92M33.55M31.07M26M35.85M41.81M47.83M51M52.15M57.41M61.21M66.73M74.81M
Short-Term Investments00000000000000000000
Accounts Receivable04.77M770K4.54M2.46M2.15M1.42M1.41M1.42M3.41M2.69M2.44M2.26M008.46M0000
Days Sales Outstanding------2.54K---16.68K7.73K4.84K--8.02K----
Inventory00000000000000034K0000
Days Inventory Outstanding--------------------
Other Current Assets2.38M621K694K595K472K505K207K331K864K01.11M002.05M2.21M-34K4.53M5.06M5.65M5.5M
Total Non-Current Assets2.8M3.05M3M2.46M2.69M1.65M16.84M16.9M16.93M16.96M17.01M17.06M17.09M17.11M17.1M17.12M17.14M17.26M17.29M17.34M
Property, Plant & Equipment1.08M1.25M2.31M914K1.06M1.08M278K307K335K363K389K414K444K468K485K507K529K650K681K726K
Fixed Asset Turnover------0.17x---0.03x0.07x0.09x0.10x0.08x0.19x0.17x0.02x0.23x0.38x
Goodwill00000000000000000000
Intangible Assets00000016.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M
Long-Term Investments0814K000000000000000000
Other Non-Current Assets1.72M985K683K1.55M1.62M570K49K79K82K81K106K131K129K130K99K99K99K99K99K99K
Total Assets21.51M26.84M25.82M32.35M33.36M37.68M37.8M39.56M52.78M52.45M46.83M57M62.7M69.72M73.98M81.8M83.8M87.81M94.35M99.94M
Asset Turnover------0.00x---0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %-35.52%-28.76%-31.7%-18.23%-36.8%-28.16%-19.29%-30.59%-15.82%-24.77%-36.69%-30.31%-25.18%-20.6%-21.59%-18.16%-22.17%44.66%43.23%145.83%
Total Current Liabilities2.92M5.89M5.39M8.42M7.36M8.59M7.93M7.22M13.82M15.05M17.45M18.46M14.36M13.05M10.28M10.92M6.89M2.29M3.23M4.36M
Accounts Payable05.08M4.66M7.77M6.88M7.86M7.3M6.56M10.64M9.28M9.29M7.9M3.67M2.38M2.08M5.21M3.46M1.69M2.55M3.8M
Days Payables Outstanding--10.75K12.03K----------------
Short-Term Debt692K00000002.49M4.98M7.46M9.92M10M10M7.5M5M2.5M000
Deferred Revenue (Current)0000000000520K489K496K00616K0000
Other Current Liabilities2.23M0000511K480K517K549K521K035K0560K591K9K778K476K584K474K
Current Ratio6.41x4.04x4.24x3.55x4.17x4.20x2.64x3.14x2.59x2.36x1.71x2.16x3.18x4.03x5.53x5.92x9.67x30.87x23.89x18.95x
Quick Ratio6.41x4.04x4.24x3.55x4.17x4.20x2.64x3.14x2.59x2.36x1.71x2.16x3.18x4.03x5.53x5.92x9.67x30.87x23.89x18.95x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities518K593K806K411K623K231K201K244K284K322K360K397K3.61M6.01M8.4M10.77M13.2M15.59M15.48M15.36M
Long-Term Debt518K000000000002.38M4.82M7.26M9.7M12.13M14.57M14.51M14.46M
Capital Lease Obligations0593K806K411K623K231K201K244K284K322K360K397K430K463K498K526K607K645K684K704K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities000000000000804K726K638K550K463K375K287K199K
Total Liabilities3.44M6.48M6.19M8.83M7.98M8.82M8.13M7.46M14.11M15.37M17.81M18.86M17.97M19.07M18.68M21.69M20.09M17.88M18.71M19.72M
Total Debt1.21M1.41M1.51M1.03M1.08M451K347K384K2.91M5.43M7.94M10.44M12.91M15.39M15.37M15.31M15.38M15.33M15.28M15.23M
Net Debt-15.12M-17.01M-19.85M-23.72M-26.65M-32.92M-18.99M-20.54M-30.64M-25.64M-18.06M-25.41M-28.9M-32.44M-35.63M-36.84M-42.02M-45.88M-51.45M-59.58M
Debt / Equity0.07x0.07x0.08x0.04x0.04x0.02x0.01x0.01x0.08x0.15x0.27x0.27x0.29x0.30x0.28x0.25x0.24x0.22x0.20x0.19x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage---------------56.84x-29.54x-26.39x-14.20x-15.24x-0.42x
Total Equity18.07M20.36M19.62M23.52M25.38M28.87M29.67M32.1M38.67M37.08M29.02M38.14M44.73M50.65M55.3M60.1M63.71M69.93M75.64M80.22M
Equity Growth %-28.78%-29.46%-33.87%-26.71%-34.38%-22.15%2.24%-15.84%-13.54%-26.8%-47.51%-36.55%-29.78%-27.57%-26.9%-25.08%-27.82%61.76%19.01%107.01%
Book Value per Share0.650.760.740.880.951.241.321.441.921.921.612.122.482.823.083.353.553.904.234.63
Total Shareholders' Equity18.07M20.36M19.62M23.52M25.38M28.87M29.67M32.1M38.67M37.08M29.02M38.14M44.73M50.65M55.3M60.1M63.71M69.93M75.64M80.22M
Common Stock28K28K27K27K27K27K23K22K22K819K817K817K817K18K18K18K18K18K18K18K
Retained Earnings-220.44M-215.72M-214.44M-209.04M-203.77M-197.3M-172.84M-163.1M-153.89M-141.79M-132.05M-121.02M-112.61M-104.05M-97.55M-91.01M-85.18M-77.46M-70.62M-63.72M
Treasury Stock00000000000000000000
Accumulated OCI-840K-823K-727K-737K-764K-763K-610K-575K-1.04M-713K-669K-799K-735K-712K-708K-699K-1.14M-701K56K1K
Minority Interest00000000000000000000